Cargando…

Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration

Extracellular Vesicles (EVs) are considered promising nanoscale therapeutics for bone regeneration. To date, EVs are typically procured from cells on 2D tissue culture plastic, an artificial environment that limits cell growth and does not replicate in situ biochemical or biophysical conditions. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Man, Kenny, Brunet, Mathieu Y., Louth, Sophie, Robinson, Thomas E., Fernandez-Rhodes, Maria, Williams, Soraya, Federici, Angelica S., Davies, Owen G., Hoey, David A., Cox, Sophie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576375/
https://www.ncbi.nlm.nih.gov/pubmed/34765595
http://dx.doi.org/10.3389/fbioe.2021.757220
_version_ 1784595863137419264
author Man, Kenny
Brunet, Mathieu Y.
Louth, Sophie
Robinson, Thomas E.
Fernandez-Rhodes, Maria
Williams, Soraya
Federici, Angelica S.
Davies, Owen G.
Hoey, David A.
Cox, Sophie C.
author_facet Man, Kenny
Brunet, Mathieu Y.
Louth, Sophie
Robinson, Thomas E.
Fernandez-Rhodes, Maria
Williams, Soraya
Federici, Angelica S.
Davies, Owen G.
Hoey, David A.
Cox, Sophie C.
author_sort Man, Kenny
collection PubMed
description Extracellular Vesicles (EVs) are considered promising nanoscale therapeutics for bone regeneration. To date, EVs are typically procured from cells on 2D tissue culture plastic, an artificial environment that limits cell growth and does not replicate in situ biochemical or biophysical conditions. This study investigated the potential of 3D printed titanium scaffolds coated with hydroxyapatite to promote the therapeutic efficacy of osteoblast-derived EVs. Ti6Al4V titanium scaffolds with different pore sizes (500 and 1000 µm) and shapes (square and triangle) were fabricated by selective laser melting. A bone-mimetic nano-needle hydroxyapatite (nnHA) coating was then applied. EVs were procured from scaffold-cultured osteoblasts over 2 weeks and vesicle concentration was determined using the CD63 ELISA. Osteogenic differentiation of human bone marrow stromal cells (hBMSCs) following treatment with primed EVs was evaluated by assessing alkaline phosphatase activity, collagen production and calcium deposition. Triangle pore scaffolds significantly increased osteoblast mineralisation (1.5-fold) when compared to square architectures (P ≤ 0.001). Interestingly, EV yield was also significantly enhanced on these higher permeability structures (P ≤ 0.001), in particular (2.2-fold) for the larger pore structures (1000 µm). Furthermore osteoblast-derived EVs isolated from triangular pore scaffolds significantly increased hBMSCs mineralisation when compared to EVs acquired from square pore scaffolds (1.7-fold) and 2D culture (2.2-fold) (P ≤ 0.001). Coating with nnHA significantly improved osteoblast mineralisation (>2.6-fold) and EV production (4.5-fold) when compared to uncoated scaffolds (P ≤ 0.001). Together, these findings demonstrate the potential of harnessing bone-mimetic culture platforms to enhance the production of pro-regenerative EVs as an acellular tool for bone repair.
format Online
Article
Text
id pubmed-8576375
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85763752021-11-10 Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration Man, Kenny Brunet, Mathieu Y. Louth, Sophie Robinson, Thomas E. Fernandez-Rhodes, Maria Williams, Soraya Federici, Angelica S. Davies, Owen G. Hoey, David A. Cox, Sophie C. Front Bioeng Biotechnol Bioengineering and Biotechnology Extracellular Vesicles (EVs) are considered promising nanoscale therapeutics for bone regeneration. To date, EVs are typically procured from cells on 2D tissue culture plastic, an artificial environment that limits cell growth and does not replicate in situ biochemical or biophysical conditions. This study investigated the potential of 3D printed titanium scaffolds coated with hydroxyapatite to promote the therapeutic efficacy of osteoblast-derived EVs. Ti6Al4V titanium scaffolds with different pore sizes (500 and 1000 µm) and shapes (square and triangle) were fabricated by selective laser melting. A bone-mimetic nano-needle hydroxyapatite (nnHA) coating was then applied. EVs were procured from scaffold-cultured osteoblasts over 2 weeks and vesicle concentration was determined using the CD63 ELISA. Osteogenic differentiation of human bone marrow stromal cells (hBMSCs) following treatment with primed EVs was evaluated by assessing alkaline phosphatase activity, collagen production and calcium deposition. Triangle pore scaffolds significantly increased osteoblast mineralisation (1.5-fold) when compared to square architectures (P ≤ 0.001). Interestingly, EV yield was also significantly enhanced on these higher permeability structures (P ≤ 0.001), in particular (2.2-fold) for the larger pore structures (1000 µm). Furthermore osteoblast-derived EVs isolated from triangular pore scaffolds significantly increased hBMSCs mineralisation when compared to EVs acquired from square pore scaffolds (1.7-fold) and 2D culture (2.2-fold) (P ≤ 0.001). Coating with nnHA significantly improved osteoblast mineralisation (>2.6-fold) and EV production (4.5-fold) when compared to uncoated scaffolds (P ≤ 0.001). Together, these findings demonstrate the potential of harnessing bone-mimetic culture platforms to enhance the production of pro-regenerative EVs as an acellular tool for bone repair. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8576375/ /pubmed/34765595 http://dx.doi.org/10.3389/fbioe.2021.757220 Text en Copyright © 2021 Man, Brunet, Louth, Robinson, Fernandez-Rhodes, Williams, Federici, Davies, Hoey and Cox. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Man, Kenny
Brunet, Mathieu Y.
Louth, Sophie
Robinson, Thomas E.
Fernandez-Rhodes, Maria
Williams, Soraya
Federici, Angelica S.
Davies, Owen G.
Hoey, David A.
Cox, Sophie C.
Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
title Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
title_full Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
title_fullStr Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
title_full_unstemmed Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
title_short Development of a Bone-Mimetic 3D Printed Ti6Al4V Scaffold to Enhance Osteoblast-Derived Extracellular Vesicles’ Therapeutic Efficacy for Bone Regeneration
title_sort development of a bone-mimetic 3d printed ti6al4v scaffold to enhance osteoblast-derived extracellular vesicles’ therapeutic efficacy for bone regeneration
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576375/
https://www.ncbi.nlm.nih.gov/pubmed/34765595
http://dx.doi.org/10.3389/fbioe.2021.757220
work_keys_str_mv AT mankenny developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT brunetmathieuy developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT louthsophie developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT robinsonthomase developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT fernandezrhodesmaria developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT williamssoraya developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT federiciangelicas developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT daviesoweng developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT hoeydavida developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration
AT coxsophiec developmentofabonemimetic3dprintedti6al4vscaffoldtoenhanceosteoblastderivedextracellularvesiclestherapeuticefficacyforboneregeneration